Cargando…
The Role of Lifestyle Intervention, in Addition to Drugs, for Diabetic Kidney Disease with Sarcopenic Obesity
Diabetic kidney disease is the leading cause of end-stage renal disease in developing and developed countries. The growing prevalence and clinical challenges of sarcopenic obesity have been associated with the frailty and disability of diabetic kidney disease. It has been reported that insulin resis...
Autores principales: | Chen, Shu-Hua, Liang, Yao-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954787/ https://www.ncbi.nlm.nih.gov/pubmed/35330131 http://dx.doi.org/10.3390/life12030380 |
Ejemplares similares
-
Sarcopenic osteoporosis, sarcopenic obesity, and sarcopenic osteoporotic obesity in the Camargo cohort (Cantabria, Spain)
por: Hernández-Martínez, Paula, et al.
Publicado: (2022) -
Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
por: Wang, Mina, et al.
Publicado: (2020) -
Sarcopenia and Sarcopenic Obesity
por: Choi, Kyung Mook
Publicado: (2013) -
Sarcopenia and sarcopenic obesity
por: Choi, Kyung Mook
Publicado: (2016) -
The Critical Role of Oxidative Stress in Sarcopenic Obesity
por: Gonzalez, Andrea, et al.
Publicado: (2021)